Galera Therapeutics stockholders elect two Class II directors and ratify KPMG as auditor

Galera Therapeutics, Inc.

Lawrence Alleva elected with 27,501,778 votes for, 3,359,405 withheld, 10,682,973 broker non-votes.
Kevin Lokay elected with 27,504,038 votes for, 3,357,145 withheld, 10,682,973 broker non-votes.
KPMG LLP ratified as independent auditor for FY2024 with 41,342,291 for, 184,580 against, 17,285 abstentions.
Annual meeting held on February 24, 2025; all proposals approved by stockholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.